Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Can a person’s immune system help prevent two types of non-small-cell lung cancer? Here’s how Robert Keith, MD, hopes to find out.
Keytruda can activate T cells that harbor latent HIV, a possible step toward a functional cure.
Three checkpoint inhibitors reduce the risk of death for patients with hard-to-treat liver and biliary tract cancers.
The antibody-drug conjugate Tivdak led to remission in 24% of cervical cancer patients.
New treatment approaches target tumors with shared characteristics, regardless of where they appear in the body.
Imfinzi tripled progression-free survival in previously treated patients with inoperable lung cancer.
Cancer and HIV are invaders that the immune system fails to detect, and the similarities don’t end there.
Individually designed vaccines help T cells recognize specific markers on tumor cells
Trials of immunotherapy drug for multiple myeloma suspended after patient deaths.
Keytruda shows promise in treating an aggressive form of the cancer that occurs more often in younger women, especially young Black women.
Findings from three clinical trials of larotrectinib were presented at this year’s American Society of Clinical Oncology in Chicago.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.